Get started
Work

1138P Delayed immune-related adverse events (irAEs) on anti-PD1-based therapy

Year: 2020
Type: article
Study design: Observational Study
DOI: 10.1016/j.annonc.2020.08.1261
Authors: C.N. Owen, X. Bai, T. Quah, S. Lo, S. Callaghan, C. Martínez-Vila, P. Bhave, I. Reijers, C.L. Gerard, S. Aspelagh, W. Xu, S.J. Welsh, S. Sandhu, J. Mangana, J.L. McQuade, P.A. Ascierto, L. Zimmer, D.B. Johnson, C. Lebbé, A.M. Menzies
Institutions: The University of Sydney, Melanoma Institute Australia, Massachusetts General Hospital, Westmead Hospital, The Christie Hospital, The Christie NHS Foundation Trust, Hospital Clínic de Barcelona, The Alfred Hospital, The Netherlands Cancer Institute, Centre Hospitalier Universitaire Vaudois, Universitair Ziekenhuis Brussel, Princess Alexandra Hospital, Cambridge University Hospitals NHS Foundation Trust, Peter MacCallum Cancer Centre, University Hospital Zurich, The University of Texas MD Anderson Cancer Center, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Essen University Hospital, Vanderbilt University Medical Center, Hôpital Saint-Louis
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3088816550
FWCI: 0.181
Cites:
Cited by: 2
Related to: 10